Keele University

Keele University

Cancer Studies

The recent completion of the human genome project has afforded new and exciting avenues for research that define the genetic basis for human disease. The research seeks to define the molecular basis of cancer and identification of genetic determinants that predispose individuals to particular disease outcomes. Frequently the research groups combine the strengths of collaborations between clinicians and basic scientists, including a focus on primary tissue or patient derived samples. The studies undertaken include both genetics and epigenetics aspects of cancer and a range of cancers (breast, pituitary, ovarian). In addition, funding from the World Cancer Research Cancer Fund has enabled a study of foetal epigenetics as determined from cord-blood samples at term. Increasingly these types of studies adopt a "whole-genome" approach looking at more than 40,000 genes in single experiments. The equipment housed within our genomics lab and through collaborations allows us to perform these types of studies. In addition these studies are reliant on in-house expertise in medical statistics and bioinformatics.

Course modules

Assessment methods


Qualification Study mode Start month Fee Course duration
PhD Full-time September 2016 - 3 years
PhD Full-time January 2017 - 3 years

Campus details

Campus name Town Postcode Region Main campus Campus Partner
Keele Campus Keele ST5 5BG West Midlands

Get in touch

Remember to mention TARGETpostgrad when contacting universities.

Key information

Telephone number: 
01782 734010